Superoxide dismutase (Ube Industries)

超氧化物歧化酶

Report date: 2023/11/15 20:04:45

Base Information

Drug NameSuperoxide dismutase (Ube Industries)
Drug Alias NameFKU-871r-hSOD
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsMyocardial IschemiaDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUbe Industries LtdAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKhyber Medical University
Inactive CompaniesAstellas Pharma IncUbe Industries Ltd
Active IndicationsDiabetic Neuropathies
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A